434. Ismail MD, Al Mutairi SE. Milk production potential of dairy camels in northern Saudi Arabia. In: *Syomposia on Dromedary Camels as Milk Producing Livestock*. Nouakchott (1998).

435. Faye B. Dairy production potential of camels. In: Cardellino R, Rosati A, Mosconi C, editors. FAO-ICAR Seminar on Camelids: Current Status of Genetic Resources, Recording and Production Systems in African, Asian and Americans Camelids. Sousse: ICAR Tech Series (2004) 11:93-104.

436. Zibaee S, Hosseini SM, Yousefi M, Taqhipour A, Kiani MA, Noras MR. Nutritional and therapeutic characteristics of camel milk in children: a systematic review. *Electron Physician*. (2015) 7:1523-8. doi: 10.19082/1523

437. Wilson RT. The one-humped camel in the word. *Options Méditerranéennes-Série Séminaires*. (1989) 2:15-7.

438. Faye B, Jaouad M, Bhrawi K, Senoussi A, Bengoumi M. Camel breeding in North Africa: current situation and perspectives/camel farming in North Africa. "Elevage camelin en Afrique du Nord: état des lieux et perspectives/camel farming in North Africa". [in French] *Rev Elev Med Vet Pays Trop*. (2014) 67:213-21. doi: 10.19182/remvt.20563

439. Gossner C, Danielson N, Gervelmeyer A, Berthe F, Faye B, Kaasik Aaslav K, et al. Human-dromedary camel interactions and the risk of acquiring zoonotic middle east respiratory syndrome coronavirus infection. *Zoonoses Publ Health*. (2016) 63:1-9. doi: 10.1111/zph.12171

440. Wardeh MF, Dawa M. Camels and dromedaries: general perspectives. In: Cardellino R, Rosati A, Mosconi C, editors. FAO-ICAR Seminar on Camelids: Current Status of Genetic Resources, Recording and Production Systems in African, Asian and Americans Camelids. Sousse: ICAR Tech Series (2004). p. 1-9.

441. Ahmad S, Yaqoob N, Hashmi N, Ahmad S, Zaman MA, Tariq M. Economic importance of camel: a unique alternative under crisis. *Pak Vet J*. (2010) 30:191-7.

442. Khalaf S. Camel racing in the Gulf. *Intl Rev Anthr Ling*. (1999) 94:85-106.

443. Seboussi R, Faye B, Alhadrami G. Factor of variation of selenium copper and zinc and enzymatic biomarker of muscle injury in the serum of *Camelus dromedarius* in UAE. "Facteurs de variation de quelques éléments trace (sélénium, cuivre, zinc) et d'enzymes témoins de la souffrance musculaire dans le sérum du dromadaire (*Camelus dromedarius*) aux Emirats arabes unis" [in French]. *Rev Elev Méd Vét Pays Trop*. (2004) 57:87-94. doi: 10.19182/remvt.9911

444. Kadim IT, Mahgoub O. Camelid genetic resources. a report on three Arabian Gulf countries. In: Cardellino R, Rosati A, Mosconi C, editors. FAO-ICAR Seminar on Camelids: Current Status of Genetic Resources, Recording and Production Systems in African, Asian and Americans Camelids. Sousse: ICAR Tech Series (2004). p. 81-92.

445. FAO. *Characterization and Value Addition to Local Breeds and their Products in the Near East and North Africa - Regional Workshop, Rabat, Morocco, 19-21 November 2012*. Rome: Animal Production and Health Report No. 3 (2014).

446. Ali Fouad E, Abu Elnaga ASM, Kandil MM. Antibacterial efficacy of *Moringa oleifera* leaf extractagainst pyogenic bacteria isolated from a dromedary camel (*Camelus dromedarius*) abscess. *Vet World*. (2019) 12:802-8. doi: 10.14202/vetworld.2019.802-808

447. Wardeh MF. Classification of the dromedary camels. *J Camel Sci*. (2004) 1:1-7.

448. Bakory MA. Preliminary genetic study of Libyan camels using DNA based PAPD and SSR markers. *Anim Sci J*. (2012) 3:6-10.

449. Aissa B. Dromedary in Algeria. "Le dromadaire en Algérie" [in French]. *Opt Méditerr.* (1989) 2:19-28.

450. Amine CY, Samir GSB, Nasreddine M, Nacera TA, Nadhira SM. Study of camelina biodiversity in southwestern of algeria. *J Life Sci*. (2013) 7:416.

451. Cherifi YA, Gaouar SBS, Guastamacchia R, El-Bahrawy KA, Abushady AMA, Sharaf AA, et al. Weak genetic structure in northern African dromedary camels reflects their unique evolutionary history. *PLoS ONE*. (2017) 12:e0168672. doi: 10.1371/journal.pone.0168672

452. Ali A, Baby B, Vijayan R. From desert to medicine: a review of camel genomics and therapeutic products. *Front Genet*. (2019) 10:17. doi: 10.3389/fgene.2019.00017

453. Mukasa-Mugerwa E. *The Camel (Camelus dromedarius): a Bibliographical Review*. Nairobi: ILRI. (1981).

454. Ramadan S, Inoue-Murayama M. Advances in camel genomics and their applications: a review. *J Anim Genet*. (2017) 45:49-58. doi: 10.5924/abgri.45.49

455. Abdallah HR, Faye B. Phenotypic classification of Saudi Arabian camel (*Camelus dromedarius*) by their body measurements. *Emir J Food Agric*. (2012) 24:272-80.

456. Massad JA. *Colonial Effects: The Making of National Identity in Jordan*. New York, NY: Columbia University Press (2012).

457. Abdelrahman MM, Aljumaa RS, Ayadi M. Selenium and iodine status of two camel breeds (*Camelus dromedaries*) raised under semi intensive system in Saudi Arabia. *Ital J Anim Sci*. (2013) 12:e14. doi: 10.4081/ijas.2013.e14

458. Al-Atiyat RM, Suliman G, AlSuhaibani E, El-Waziry A, Al-Owaimer A, Basmaeil S. The differentiation of camel breeds based on meat measurements using discriminant analysis. *Trop Anim Health Prod*. (2016) 48:871-8. doi: 10.1007/s11250-015-0990-5

459. Harrigan P. At Mazayin al-Ibl, spectators admire a prizewinning herd. *Saudi Aramco World*. (2008) 59:48-57.

460. Khalaf S. Poetics and politics of newly invented traditions in the Gulf: camel racing in the United Arab Emirates. *Ethnology*. (2000) 39:243-61. doi: 10.2307/3774109

461. Asghar SM, Farhat S, Naiz S. Camel jockeys of Rahimyar Khan. In: Coleridge A, Qadri G, editors. *Findings of a Participatory Research on Life and Situation of Child Camel Jockeys*. Peshawar: Save the Children Sweden (2005).

462. Moore JE, McCalmont M, Xu J, Nation G, Tinson AH, Crothers L, et al. Prevalence of faecal pathogens in calves of racing camels (*Camelus dromedarius*) in the United Arab Emirates. *Trop Anim Hlth Prod*. (2002) 34:283-7. doi: 10.1023/A:1015626601014

463. Chuluunbat B, Charruau P, Silbermayr K, Khorloojav T, Burger PA. Genetic diversity and population structure of Mongolian domestic Bactrian camels (*Camelus bactrianus*). *Anim Genet*. (2014) 45:550-8. doi: 10.1111/age.12158

464. Ming L, Yi L, Guo FC, Siriguleng S, Jirimutu J. Molecular phylogeny of the Bactrian camel based on mitochondrial cytochrome b gene sequences. *Genet Mol Res*. (2016) 15:1-8. doi: 10.4238/gmr.15038983

465. Othman OE, Abd El-Kader, HAM, Alam SS, Abd El-Aziem SH. Cytochrome b conservation between six camel breeds reared in Egypt. *J Genet Eng Biotechnol*. (2017) 15:1-6. doi: 10.1016/j.jgeb.2017.04.006

466. Jirimutu Wang Z, Ding G, Chen G, Sun Y, Sun Z, Zhang H, et al. Genome sequences of wild and domestic bactrian camels. *Nat Commun*. (2012) 3:1202. doi: 10.1038/ncomms2192

467. Wani NA, Wernery U, Hassan FA, Wernery R, Skidmore JA. Production of the first cloned camel by somatic cell nuclear transfer. *Biol Reprod*. (2010) 82:373-9. doi: 10.1095/biolreprod.109.081038

468. Wani NA, Vettical BS, Hong SB. First cloned Bactrian camel (*Camelus bactrianus*) calf produced by interspecies somatic cell nuclear transfer: a step towards preserving the critically endangered wild Bactrian camels. *PLoS ONE*. (2017) 12:e0177800. doi: 10.1371/journal.pone.0177800

469. Richard D, Gérard D. Camel milk production in Ethiopia. "La production laitière des dromadaires Dankali (Ethiopie)". [in French]. *Rev Elev Med Vét Pays Trop*. (1989) 42:97-103.

470. Farah Z, Mollet M, Younan M, Dahir R. Camel dairy in Somalia: limiting factors and developmental potential. *Livestock Sci*. (2007) 110:187-91. doi: 10.1016/j.livsci.2006.12.010

471. Rousset E, Russo P, Pepin M, Raoult D. Epidémiologie de la fièvre Q animale. Situation en France [in French]. *Méd Mal Infect*. (2001) 31:233-46. doi: 10.1016/S0399-077X(01)80064-0

472. Faye B. Surveillance and control procedures for camel diseases. In: *Regional Workshop Surveillance and Control of Camels and Wildlife Diseases in the Middle East*. Sanaa (2003).

473. Pinauldt G. Epizootics and geographic distribution of lifestok trade in the horn of Africa. "Epizooties et géographie du commerce du bétail dans la Corne de l'Afrique. La guerre des quarantaines dans la région nord-Somali". *Echogeo*. (2009) 8. doi: 10.4000/echogeo.11021

474. Perry BD, Grace D, Sones K. Current drivers and future directions of global livestock disease dynamics. *Proc Natl Acad Sci USA*. (2011) 110:20871-7. doi: 10.1073/pnas.1012953108

475. Amenu K, Szonyi B, Grace D, ET AL. Important knowledge gaps among pastoralists on causes and treatment of udder health problems in livestock in
Southern Ethiopia: results of qualitative investigation. BMC Vet Res. (2017) 13:303. doi: 10.1186/s12917-017-1222-1

476. Ackland JR, Worswick DA, Marmion BP. Vaccine prophylaxis of Q fever—a follow-up study of the efficacy of Q-Vax (CSL) 1985–1990. Med J Austral. (1994) 160:704–8. doi: 10.5694/j.1326-5377.1994.tb125909.x

477. Gefenaite G, Munster JM, van Houdt R, Hak E. Effectiveness of the Q fever vaccine: a metaanalysis. Vaccine. (2011) 29:395–8. doi: 10.1016/j.vaccine.2010.11.008

478. Sellens E, Norris JM, Dhand NK, Heller J, Hayes L, Gidding HF, et al. Q fever knowledge, attitudes and vaccination status of Australia's veterinary workforce in 2014. PLoS ONE. (2016) 11:e0146819. doi: 10.1371/journal.pone.0146819

479. Gikas A, Spyridaki I, Scoulica E, Psaroulaki A, Tselentis Y. In vitro susceptibility of *Coxiella burnetii* to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin. *Antimicrob Agents Chemother.* (2001) 45:3276–8. doi: 10.1128/AAC.45.11.3276-3278.2001

480. Dumler SJ. Q fever. *Curr Treat Options Infect Dis.* (2002) 4:437–45.

481. Melenotte C, Million M, Raoult D. New insights in *Coxiella burnetii* infection: diagnostic and therapeutic update. *Expert Rev Anti Infect Ther.* (2019) 6:1–12. doi: 10.1080/14787210.2020.1699055

482. van den Brom R, van Engelen E, Roest HI, van der Hoek W, Vellema P. *Coxiella burnetii* infections in sheep or goats; an opinionated review. *Vet Microbiol.* (2015) 181:119–29. doi: 10.1016/j.vetmic.2015.07.011

483. Ormsbee RA, Bell EJ, Lackman DB. Antigens of *Coxiella burnetii*. *J Immunol.* (1962) 88:741–9.

484. Acha PN, Szyfres B. Q fever. In: *Zoonoses and Communicable Diseases Common to Man and Animals, Vol 2: Chlamydioses, Rickettsioses, and Viroses*. 3rd ed. Washington, DC: The Pan American Health Organization (2003). p. 16–27.

485. Schmeer N, Miller HP, Langel J, Krauss H, Frost JW, Wieda J. Q fever vaccines for animals. *Zentralbl Bakteriol Parasitenkd Infektionskr Hyg.* (1987) 267:79–88. doi: 10.1016/S0176-6724(87)80191-8

486. Lang GH, Prescott JF, Williams JC. Serological response in sheep vaccinated against *Coxiella burnetii* (Q fever). *Can Vet J.* (1994) 35:373–4.

487. Kazar J, Schramek S, Lisak V, Brezina R. Antigenicity of Chloroform-methanol-treated *Coxiella burnetii* preparations. *Acta Virol.* (1987) 31:158–67.

488. Guatteo R, Seegers H, Joly A, Beauveau F. Prevention of *Coxiella burnetii* shedding in infected dairy herds using a phase I C. *burnetii* inactivated vaccine. Vaccine. (2008) 26:4320–8. doi: 10.1016/j.vaccine.2008.06.023

489. Rousset E, Durand B, Champion JL, Prigent M, Dufour P, Forfait C, et al. Efficiency of a phase I vaccine for the reduction of vaginal *Coxiella burnetii* shedding in a clinically affected goat herd. *Clin Microbiol Infect.* (2009) 15:188–9. doi: 10.1111/j.1469-0691.2008.02220.x

490. Hogerwerf L, van den Brom R, Roest HIJ, Bouma A, Vellema P, Pietterse M, et al. Reduction of *Coxiella burnetii* prevalence by vaccination of goats and sheep, the Netherlands. *Emerg Infect Dis.* (2011) 17:379–86. doi: 10.3201/eid1703.101157

491. Gonzalez-Barrio D, Ortiz JA, Ruiz-Fons F. Estimating the efficacy of commercial phase I inactivated vaccine in decreasing the prevalence of *Coxiella burnetii* infection and shedding in red derr (*Cervus elaphus*). *Front Vet Sci.* (2017) 4:208. doi: 10.3389/fvets.2017.00208

492. Arricau-Bouvery N, Souriau A, Bodier C, Dufour P, Rousset E, Rodolakis A. Effect of vaccination with phase I and phase II *Coxiella burnetii* vaccines in pregnant goats. Vaccine. (2005) 23:4392–402. doi: 10.1016/j.vaccine.2005.04.010

493. Coche B. Bovine Q fever in France. "La fièvre Q bovine en France. Aspects pratiques et importance de la sérologie" [in French]. Point Vet. (1981) 12:95–100.

494. Rodolakis A. Chlamydia and Q fever as abortion agents and their implication in zoonoses. "Chlamydiose et fièvre Q: agents d'avortements et zoonoses ?" [in French]. Point Vet. (1994) 26:845–50.

495. Rousset E, Eon L, Russo P, Pepin M, Aubert M. La fièvre Q: épidémiologie d'une zoonose [in French]. *Bull Group Tech Vét.* (2002) 17:9–15.

496. Szymanska-Czerwinska M, Niemczuk K. Evaluation of the effectiveness of Q fever treatment with oxytetracycline. *Bull Vet Inst Pulawy.* (2012) 56:513–7. doi: 10.2478/v10213-012-0090-5

497. Cerf O, Condron R, *Coxiella burnetii* and milk pasteurization: an early application of the precautionary principle? *Epidemiol Infect.* (2006) 134:946–51. doi: 10.1017/S0950268806005978

498. Astobiza I, Barandika JF, Juste RA, Hurtado A, Garcia-Perez AL. Evaluation of the efficacy of oxytetracycline treatment followed by vaccination against Q fever in a highly infected sheep flock. Vet J. (2013) 196:81–5. doi: 10.1016/j.tvjl.2012.07.028

499. Kersh GJ, Fitzpatrick KA, Self JS, et al. Presence and persistence of *coxiella burnetii* in the environments of goat farms associated with a Q fever outbreak. *Appl Environ Microbiol.* (2013) 79:1697–703. doi: 10.1128/AEM.03472-12

500. Moffat MAJ. Zoonotic implications of Q fever and Chlamydial infections in animals and man: part1-Q fever. *Ir Vet J.* (1990) 43:115–7.

501. Woldehietz W, Aitken ID. Coxiellosis (Q fever). In: Woldehietz W, Ristic M, editors. *Rickettsial and Chlamydial Diseases of Domestic Animals*. Oxford: Pergamon Press (1993). p. 131–51.

502. Orfila J. Chapitre 50: Rickettsiales [in French]. In: Le Minor L, Véron M, editors. *Bactériologie Médicale*. 2 éd. Paris: Flammarion Médecine-Sciences (1989). p. 1069–71.

503. Behymer D, Riemann P. *Coxiella burnetii* infection (Q fever). *J Am Vet Assoc.* (1989) 194:164–767.

504. Arricau-Bouvery N, Souriau A, Moutoussamy A, Ladenise K, Rodolakis A. Study of *Coxiella burnetii* excretion in an experimental goat model and decontamination of dung with calcium Cyanamid. *Rencontres autour des Recherches sur les Ruminants*. (2001) 8:153–6.

505. Blanc GM, Maurica A. Présence du virus de la 'Q fever' dans le Maroc méridional [in French]. *Bull Acad Natl Med.* (1947) 131:138–43.

506. Edouard S, Million M, Casalta JP, Collart F, Amphoux B, Raoult D. Low antibodies titer and serological cross-reaction between *Coxiella burnetii* and Legionella pneumophila challenge the diagnosis of mediastinitis, an emerging Q fever clinical entity. *Infection*. (2017) 45:911–5. doi: 10.1007/s15010-017-1048-6

507. Bouhous A, Aissi M, Harhoura KH. Etude des Ixodidae chez le dromadaire dans le sud algérien, région d'Adrar [Study of Ixodidae on camels in Southwest Algeria, Adrar region] [in French]. *Annal Méd Vét.* (2008) 152:52–8.

508. El Idrissi AH, Manyari A, Benkirane A. Fréquence des avortements infectieux des ovins au Maroc (Région de Zaer et du Moyen Atlas) [in French]. *Actes Inst Agron Vét.* (1995) 15:11–4.

509. El Jay S, Bouslikhane M, El Idrissi AH. Epidemiological monitoring of small ruminant abortions in pastoral areas of Morocco. "Suivi épidémiologique des avortements de petits ruminants dans les zones pastorales du Maroc." *Actes Inst Agron Vet.* (2003) 23:95–100.

510. Benkirane A, Essamkaoui S, El Idrissi A, Lucchese L, Natale A. A sero-survey of major infectious causes of abortion in small ruminants in Morocco. *Vet Italian.* (2015) 51:25–30. doi: 10.12834/VetIt.389.1814.1

511. Cleaveland S, Sharp J, Abela-Ridder B, Allan KJ, Buza J, Crump JA, et al. One Health contributions towards more effective and equitable approaches to health in low and middle-income countries. *Phil Trans R Soc.* (2017) 372. doi: 10.1098/rstb.2016.0168

**Conflict of Interest:** The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2020 Devaux, Osman, Million and Raoult. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.